Showing results (931-940 of 1,341) with videos related to

Sort By:
Pageof 135
Neuro-Oncology Advances|July 10, 2024
Advancing precision prognostication in neuro-oncology: Machine learning models for data-driven personalized survival predictions in IDH-wildtype glioblastomaMert Karabacak, Pemla Jagtiani, Long Di, et al.
Neuro-Oncology Advances|July 9, 2024
Phase I and pharmacodynamic study of arsenic trioxide plus radiotherapy in patients with newly diagnosed glioblastomaSamuel Ryu, Xiaobu Ye, Jeffrey J Olson, et al.
Neuro-Oncology Advances|July 22, 2024
Germline susceptibility from broad genomic profiling of pediatric brain cancersElaine R Mardis, Samara L Potter, Kathleen M Schieffer, et al.
Neuro-Oncology Advances|July 1, 2024
Survival after resection of malignant peripheral nerve sheath tumors: Introducing and validating a novel type-specific prognostic modelIbtissam Acem, Ewout W Steyerberg, Marta Spreafico, et al.
Neuro-Oncology Advances|July 3, 2024
Imaging meningioma biology: Machine learning predicts integrated risk score in WHO grade 2/3 meningiomaOlivia Kertels, Claire Delbridge, Felix Sahm, et al.
Neuro-Oncology Advances|April 10, 2024
Advancing noninvasive glioma classification with diffusion radiomics: Exploring the impact of signal intensity normalizationMartha Foltyn-Dumitru, Marianne Schell, Felix Sahm, et al.
Neuro-Oncology Advances|January 30, 2024
De Ritis ratio in elderly glioblastoma patients treated with chemoradiation: A comprehensive analysis of serum biomarkersJina Kim, Hye In Lee, In Ah Kim, et al.
Neuro-Oncology Advances|January 22, 2024
Challenges and limitations of clinical trials in the adolescent and young adult CNS cancer population: A systematic reviewEmma M Byrne, Maeve Pascoe, Diane Cooper, et al.
Neuro-Oncology Advances|February 5, 2024
Differences in methylation profiles between long-term survivors and short-term survivors of IDH-wild-type glioblastomaMatthijs van der Meulen, Ronald C Ramos, Mathew R Voisin, et al.
Neuro-Oncology Advances|January 30, 2024
Molecular prognostication in grade 3 meningiomas and p16/MTAP immunohistochemistry for predicting CDKN2A/B statusKira Tosefsky, Karina Chornenka Martin, Alexander D Rebchuk, et al.
Pageof 135